MILAN, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Intesa Sanpaolo reported record nine-month net income of €7.6 billion, including €2.4 billion in the third quarter, confirming the Group’s strong performance ...

COPENHAGEN, Denmark, October 31, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a business ...

Svitzer today announced the signing of a landmark Letter of Intent (LoI) with Cochin Shipyard Limited (CSL) to construct a new generation of electric TRAnsverse tugs in India. The agreement marks a ...

Cosmos Health Inc.  ("Cosmos Health" or the “Company”) (NASDAQ:COSM)  , a diversified, vertically integrated global healthcare group, today announced the initiation of a new research and development ...

Neste Corporation has on 31 October 2025 transferred 30 449 treasury shares to the President and CEO as a participant of the Restricted Share Plans 2022-2024, 2023-2025 and 2024-2026 of Neste ...

Honkarakenne and SAIPRO GROUP LLC Signed Agreement on a Strategic Partnership to Further Develop the Green Hills Premium Resort and Santa Claus Park among other planned and envisioned resorts in ...

Aarhus, October 31, 2025 – The Region of Southern Denmark has signed a contract with Trifork for the development, implementation, and maintenance of the national Shared Public Treatment Platform ...

TEL AVIV, Israel, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at two ...

Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company BOOST Pharma has presented new long-term data from the BOOSTB4 phase 1/2 trial with the company’s cell ...

As significant outcomes of the forum, the opening day saw the release of the "Consensus 2025: Uniting for Deep-sea Big Science, Pioneering Global Hadal Frontiers", the establishment of the Underwater ...

COPENHAGEN, Denmark, October 31, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a business ...

The acquisition represents Copenhagen Infrastructure Partner’s entry into the UK bioenergy market and is the fourth investment in CIP’s Advanced Bioenergy Fund (CI ABF I).